← Back
$MREO All transactions

Mereo BioPharma Group plc

A

$ Value

$0

Shares

345,000

Price

$0

Filed

Feb 2

Insider

Name

Scots-Knight Denise

Title

Chief Executive Officer

CIK

0001297000

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

345,000

Footnotes

25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter. | Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. | Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date.

Filing Info

Accession No.

0001193125-26-033751

Form Type

4

Issuer CIK

0001719714

Scots-Knight Denise's History

Date Ticker Type Value
2026-02-01 MREO A $0
2026-02-01 MREO A $0
2026-02-01 MREO A $0
2025-11-28 ELAN A $0

Other Insiders at MREO (90d)

Insider Bought Sold Last
WYZGA MICHAEL S 2026-02-26
PAKIANATHAN DEEPIKA 2026-02-26
Scots-Knight Denise
Chief Executive Officer
2026-02-01
Lewicki John A.
Chief Scientific Officer
2026-02-01
Yoskowitz Marc J 2026-02-26
Jenkins Annalisa 2026-02-26
Sermon Charles
General Counsel
2026-02-01
Jacquet Pierre 2026-02-26
Bender Jeremy 2026-02-26
Shames Daniel 2026-02-26
Fox Christine Ann
Chief Financial Officer
2026-02-01
Ekblom Anders 2026-02-26
Hughes-Wilson Alexandra
See Remarks
2026-02-01